Clinical Application of Pharmacogenetic Markers in the Treatment of Dermatologic Pathologies
Dermatologic pathologies are the fourth most common cause of non-fatal disease worldwide; however, they produce a psychosocial, economic, and occupational impact equal to or greater than other chronic conditions. The most prevalent are actinic keratosis, followed by basal-cell carcinoma, in a lesser...
Saved in:
Main Authors: | Cristina Membrive Jiménez (Author), Cristina Pérez Ramírez (Author), Almudena Sánchez Martín (Author), Sayleth Vieira Maroun (Author), Salvador Arias Santiago (Author), María Carmen Ramírez Tortosa (Author), Alberto Jiménez Morales (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Variation in Actionable Pharmacogenetic Markers in Natives and Mestizos From Mexico
by: Vanessa Gonzalez-Covarrubias, et al.
Published: (2019) -
Gefitinib-Induced Severe Dermatological Adverse Reactions: A Case Report and Pharmacogenetic Profile
by: Mariana Vieira Morau, et al.
Published: (2024) -
Secreted Frizzled - related Protein 4 y el cáncer de mama
by: José María Gálvez-Navas, et al.
Published: (2021) -
Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients
by: Yasmin Cura, et al.
Published: (2023) -
COMPREHENSIVE EVALUATION OF COMBINED PHARMACOTHERAPY OF CARDIAC PATHOLOGY CONSIDERING EXOGENOUS AND PHARMACOGENETIC FACTORS
by: Arsen Kornilov, et al.
Published: (2016)